E. Patin

OX40 and 4-1BB delineate distinct immune profiles in sarcoma

T. Fenton, K. Thway, M. McLaughlin, 2022, Oncoimmunology.

4-1BB is a target for immunotherapy in patients with undifferentiated pleomorphic sarcoma

A. Miah, K. Thway, M. Dillon, 2020, bioRxiv.

Neutrophilic NLRP3 inflammasome-dependent IL-1β secretion regulates the γδT17 cell response in respiratory bacterial infections

J. Sirard, B. Ryffel, J. Veening, 2017, Mucosal Immunology.